Intelligent Generative AI Handling – Aaron Weismann – CSP #163
Full Audio
View Show IndexSegments
1. Intelligent Generative AI Handling – Aaron Weismann – CSP #163
Generative AI security and integrity. This is important to me because it's a cool new commercially available technology that promises efficiency and time savings--and therefore everyone wants to use it without a thorough understanding of how to secure data used with it or correcting model bias introduced through improper governance. The implications, particularly in the healthcare space, are significant where AI-driven care decisions can drift away from optimal care and have the potential to expose significant care gaps.
This segment is sponsored by Darktrace. Visit https://cisostoriespodcast.com/darktrace to learn more about them!
Sponsored By
Guest
Aaron has been the CISO for Main Line Health, a health system based in Philadelphia, PA, for the past four years. Prior to that, he was the CISO for the Massachusetts Executive Office of Health and Human Services, which provided support and care services for over 3 million Massachusetts residents.
Prior to undertaking a career in cybersecurity, Aaron was an attorney who primarily worked on data security and privacy matters plus large-scale IT contracting.
Host
Todd Fitzgerald has built information Fortune 500/large company security programs for 20 years. Todd serves as VP, Cybersecurity Strategy and Chairman of the Cybersecurity Collaborative Executive Committee, was named 2016–17 Chicago CISO of the Year, ranked Top 50 Information Security Executive, authored 4 books including #1 Best Selling and 2020 CANON Hall of Fame Winner CISO COMPASS: Navigating Cybersecurity Leadership Challenges with Insights from Pioneers (2019), ground-breaking CISO Leadership: Essential Principles for Success, as well as contributions to a dozen others. Todd held senior leadership positions at Northern Trust, Grant Thornton International, Ltd, ManpowerGroup, WellPoint (Anthem) Blue Cross Blue Shield/ National Government Services, Zeneca/Syngenta, IMS Health and American Airlines.
